Carvedilol therapy effects on structural and electric remodeling in chronic heart failure
Aim. To assess the effects of combination therapy with ACE inhibitors and carvedilol on cardiac remodeling, cardiac arrhythmias, and quality of life (QoL) in patients with mild to moderate chronic heart failure (CHF).Material and methods. The study included 109 patients with mild to moderate CHF, de...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2008-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1066 |
| _version_ | 1797882745705201664 |
|---|---|
| author | E. V. Minakov R. A. Khokhlov T. N. Kusnetsova Yu. V. Popovskaya E. E. Tsareva |
| author_facet | E. V. Minakov R. A. Khokhlov T. N. Kusnetsova Yu. V. Popovskaya E. E. Tsareva |
| author_sort | E. V. Minakov |
| collection | DOAJ |
| description | Aim. To assess the effects of combination therapy with ACE inhibitors and carvedilol on cardiac remodeling, cardiac arrhythmias, and quality of life (QoL) in patients with mild to moderate chronic heart failure (CHF).Material and methods. The study included 109 patients with mild to moderate CHF, developed in arterial hypertension, coronary heart disease, or their combination with diabetes mellitus and obesity. Initial carvedilol dose was 6,25-25 mg/d. At baseline, 3, 6, and 9 months later, physical examination, biochemical assay, lectrocardiography,QoL and clinical outcome assessment were performed. Doppler echocardiography and 24-hour electrocardiogram (ECG) monitoring were performed at baseline and 6 months later.Results. CHF therapy, including the combination of ACE inhibitor and carvedilol, was associated with reduction in structural left ventricular (LV) remodeling, as well as with systolic and diastolic LV function normalization. According to 24-hour ECG monitoring data, the total number of supraventricular (including paired and grouped) and ventricular (including paired ectopic complexes) extrasystoles significantly decreased. Combination, carvedilol-including CHF therapy resulted in significant QoL and clinical prognosis improvement.Conclusion. In patients with mild to moderate CHF, carvedilol demonstrated its clinical effectiveness, including reduced structural and electric remodeling progression. |
| first_indexed | 2024-04-10T03:39:33Z |
| format | Article |
| id | doaj.art-77ceb21e772c47ed9ddfab74d37a0759 |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:39:33Z |
| publishDate | 2008-02-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-77ceb21e772c47ed9ddfab74d37a07592023-03-13T07:23:14Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252008-02-01716976779Carvedilol therapy effects on structural and electric remodeling in chronic heart failureE. V. Minakov0R. A. Khokhlov1T. N. Kusnetsova2Yu. V. Popovskaya3E. E. Tsareva4Воронежская государственная медицинская академия им. Н.Н.БурденкоМежтерриториальный кардиологический центр Воронежской областной клинической больницы, г. ВоронежМежтерриториальный кардиологический центр Воронежской областной клинической больницы, г. ВоронежМежтерриториальный кардиологический центр Воронежской областной клинической больницы, г. ВоронежМежтерриториальный кардиологический центр Воронежской областной клинической больницы, г. ВоронежAim. To assess the effects of combination therapy with ACE inhibitors and carvedilol on cardiac remodeling, cardiac arrhythmias, and quality of life (QoL) in patients with mild to moderate chronic heart failure (CHF).Material and methods. The study included 109 patients with mild to moderate CHF, developed in arterial hypertension, coronary heart disease, or their combination with diabetes mellitus and obesity. Initial carvedilol dose was 6,25-25 mg/d. At baseline, 3, 6, and 9 months later, physical examination, biochemical assay, lectrocardiography,QoL and clinical outcome assessment were performed. Doppler echocardiography and 24-hour electrocardiogram (ECG) monitoring were performed at baseline and 6 months later.Results. CHF therapy, including the combination of ACE inhibitor and carvedilol, was associated with reduction in structural left ventricular (LV) remodeling, as well as with systolic and diastolic LV function normalization. According to 24-hour ECG monitoring data, the total number of supraventricular (including paired and grouped) and ventricular (including paired ectopic complexes) extrasystoles significantly decreased. Combination, carvedilol-including CHF therapy resulted in significant QoL and clinical prognosis improvement.Conclusion. In patients with mild to moderate CHF, carvedilol demonstrated its clinical effectiveness, including reduced structural and electric remodeling progression.https://cardiovascular.elpub.ru/jour/article/view/1066карведилолхроническая сердечная недостаточностьремоделированиеаритмиикачество жизни |
| spellingShingle | E. V. Minakov R. A. Khokhlov T. N. Kusnetsova Yu. V. Popovskaya E. E. Tsareva Carvedilol therapy effects on structural and electric remodeling in chronic heart failure Кардиоваскулярная терапия и профилактика карведилол хроническая сердечная недостаточность ремоделирование аритмии качество жизни |
| title | Carvedilol therapy effects on structural and electric remodeling in chronic heart failure |
| title_full | Carvedilol therapy effects on structural and electric remodeling in chronic heart failure |
| title_fullStr | Carvedilol therapy effects on structural and electric remodeling in chronic heart failure |
| title_full_unstemmed | Carvedilol therapy effects on structural and electric remodeling in chronic heart failure |
| title_short | Carvedilol therapy effects on structural and electric remodeling in chronic heart failure |
| title_sort | carvedilol therapy effects on structural and electric remodeling in chronic heart failure |
| topic | карведилол хроническая сердечная недостаточность ремоделирование аритмии качество жизни |
| url | https://cardiovascular.elpub.ru/jour/article/view/1066 |
| work_keys_str_mv | AT evminakov carvediloltherapyeffectsonstructuralandelectricremodelinginchronicheartfailure AT rakhokhlov carvediloltherapyeffectsonstructuralandelectricremodelinginchronicheartfailure AT tnkusnetsova carvediloltherapyeffectsonstructuralandelectricremodelinginchronicheartfailure AT yuvpopovskaya carvediloltherapyeffectsonstructuralandelectricremodelinginchronicheartfailure AT eetsareva carvediloltherapyeffectsonstructuralandelectricremodelinginchronicheartfailure |